VIZGEN
Vizgen is a privately held biotech company developing the next generation of spatially resolved, single-cell transcriptomics technology and toolbox. The company's patented MERFISH technology enables massively multiplexed, genome-scale nucleic acid imaging with high accuracy and detection efficiency at subcellular resolution. The high throughput and resolution and the low cost per cell achieved by the technology will enable a wide range of tissue-scale basic research and development and will be instrumental to efforts to discover and map cell types and states in a range of tissues and organisms.
VIZGEN
Industry:
Biotechnology Health Care Life Science Medical
Founded:
2019-03-07
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.vizgen.com
Total Employee:
51+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
136.2 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving Apple Mobile Web Clips Icon Google Font API Google Tag Manager WordPress Content Delivery Network Amazon SSL By Default
Similar Organizations
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Eikon Therapeutics
Eikon Therapeutics is a biopharmaceutical company that develops live-cell resolution microscopy and engineering for drug discovery.
Lindus Health
We accelerate clinical trials for biotech and healthtech pioneers
Ossium Health
Ossium Health is building the world's first bone marrow bank to treat blood cancers
Redcliffe Labs
Redcliffe is a one-stop diagnostic platform offering a wide selection of tests to choose from and delivering care closer to the customer.
Rejuvenate Bio
Rejuvenate Bio is a biotechnology company that develops novel gene therapies for dogs.
Tango Therapeutics
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Volastra Therapeutics
Volastra Therapeutics is a biotechnology company developing novel therapies for the treatment of metastatic cancers.
Current Advisors List
Current Employees Featured
Founder
Investors List
Blue Water Life Science Advisors
Blue Water Life Science Advisors investment in Series C - Vizgen
Sofina
Sofina investment in Series C - Vizgen
Northpond Ventures
Northpond Ventures investment in Series C - Vizgen
ARCH Venture Partners
ARCH Venture Partners investment in Series C - Vizgen
Novalis LifeSciences
Novalis LifeSciences investment in Series C - Vizgen
Tao Capital Partners
Tao Capital Partners investment in Series C - Vizgen
Pura Vida Investments
Pura Vida Investments investment in Series B - Vizgen
Northpond Ventures
Northpond Ventures investment in Series B - Vizgen
Novalis LifeSciences
Novalis LifeSciences investment in Series B - Vizgen
Tao Capital Partners
Tao Capital Partners investment in Series B - Vizgen
Key Employee Changes
| Date | New article |
|---|---|
| 2021-10-18 | Vizgen Appoints Dale Levitzke as Senior VP Global Sales and Support |
Official Site Inspections
http://www.vizgen.com Semrush global rank: 2.66 M Semrush visits lastest month: 6.59 K
- Host name: 134.155.190.35.bc.googleusercontent.com
- IP address: 35.190.155.134
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Vizgen"
Vizgen - Crunchbase Company Profile & Funding
Vizgen is a privately held biotech company developing the next generation of spatially resolved, single-cell transcriptomics technology and toolbox. The company's patented MERFISH technology enables massively multiplexed, …See details»
Single-Cell Spatial Genomics | Vizgen
Vizgen Launches Certified Service Provider (CSP) Program, Expanding Access to Single-Cell Spatial Genomics Technology Read More. GEN. 10.30.2024 Top 10 Spatial Biology …See details»
About Us - Vizgen
Simona brings to Vizgen more than 25 years of experience in the life science industry. Prior to coming to Vizgen, she served as General Counsel and Corporate Secretary for Cell Signaling …See details»
Vizgen - LinkedIn
Vizgen | 16,013 followers on LinkedIn. Confidently take your research to new depths with MERSCOPE Ultra integrating single-cell and spatial multiomics analysis | Ultivue recently …See details»
Vizgen Company Profile 2025: Valuation, Funding
Vizgen General Information Description. Developer of biomolecule profiling technology designed to bring new insight into biological systems and disease. The company's technology focuses on unlocking the power of spatially …See details»
Vizgen - VentureRadar
" Vizgen is developing the next generation of genomic profiling tools that enable researchers to gain new insight into the biological systems that underlie human health and disease with …See details»
Vizgen - Contacts, Employees, Board Members, Advisors & Alumni …
Organization. Vizgen . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contacts 140. About. Vizgen has 7 current employee …See details»
Vizgen Company Profile - Office Locations, Competitors, Revenue …
Vizgen has 5 employees at their 1 location and $51 m in total funding,. See insights on Vizgen including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»
Vizgen - Overview, News & Similar companies | ZoomInfo.com
Vizgen Announces Significant Win in Ongoing Patent Litigation Against 10x Genomics and Harvard University CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vizgen, Inc., the life science …See details»
Vizgen and Ultivue Merge to Enable Deeper Insights into Disease ...
CAMBRIDGE, Mass., October 09, 2024--Vizgen and Ultivue Merge to Enable Deeper Insights into Disease Mechanisms and Drive Innovation in Spatial Multi-OmicsSee details»
Vizgen and Ultivue Merge to Enable Deeper Insights into Disease ...
Oct 9, 2024 The companies are combining to establish a single organization uniquely positioned to drive future technology breakthroughs and respond to researchers’ desire for unified …See details»
Vizgen - Work in biotech
Vizgen is building microscopy-based tools for spatial genomics. The last decade has seen rapid advances in the speed and scale of DNA sequencing. ... Publications Cell-type-specific 3D …See details»
Certified Service Providers - Vizgen
This equips them to deliver unparalleled data quality and services for Vizgen’s groundbreaking MERSCOPE Ultra TM Platform. Our cutting edge MERSCOPE Ultra TM Platform offers an all …See details»
Vizgen and Ultivue Merge to Enable Deeper Insights into Disease ...
Oct 9, 2024 The companies are combining to establish a single organization uniquely positioned to drive future technology breakthroughs and respond to researchers’ desire for unified …See details»
Spatial biology companies Vizgen and Ultivue merge amid …
Oct 9, 2024 Vizgen and Ultivue, two companies at the forefront of developing technologies that allow scientists to map the molecular makeup of cells in exquisite detail, are joining forces. …See details»
Vizgen and Ultivue Merge to Enable Deeper Insights into Disease ...
Oct 9, 2024 Vizgen, Inc., a life science company dedicated to improving human health by visualizing single-cell spatial genomics information, and Ultivue, Inc., a market leader in …See details»
Vizgen's Antitrust Claims Tossed From 10x, Harvard Patent Suit
3 days ago Judge Matthew F. Kennelly dismissed both of Vizgen’s antitrust counterclaims against 10x and Harvard, according to an opinion issued Jan. 3 in the US District Court for the …See details»
Vizgen and Ultivue Merge to Enable Deeper Insights into Disease ...
Oct 9, 2024 The companies are combining to establish a single organization uniquely positioned to drive future technology breakthroughs and respond to researchers’ desire for unified …See details»
Molecular and cellular dynamics of the developing human neocortex
1 day ago Tripotential intermediate progenitor cells are responsible for the local production of GABAergic neurons, oligodendrocyte precursor cells and astrocytes in the human …See details»
Court Allows Vizgen Counterclaims Against Harvard in 10x …
3 days ago Kennelly also allowed some of Vizgen's allegations of improper pricing by 10x to go to trial. Last year, he allowed Vizgen to expand its antitrust allegations against 10x. According …See details»